Motivation: Gene set analysis is a powerful tool to study the coordinative change of time-course data. However, most existing methods only model the overall change of a gene set, yet completely overlooked heterogeneous time-dependent changes within sub-sets of genes. Results: We have developed a novel statistical method, Phantom, to investigate gene set heterogeneity. Phantom employs the principle of multi-objective optimization to assess the heterogeneity inside a gene set, which also accounts for the temporal dependency in time-course data. Phantom improves the performance of gene set based methods to detect biological changes across time. Availability and implementation: Phantom webpage can be accessed at: http://www.baylorhealth. edu/Phantom. R package of Phantom is available at https://cran.r-project.org/web/packages/phan tom/index.html.
Introduction
Gene set analysis has been widely applied to study time-course expression data (Subramanian, et al., 2005; Turner, et al., 2015) . Most time-course gene set methods only model the overall expressional change across time, which completely overlook potential 'heterogeneity' within gene sets. Adaptations have been proposed in previous literatures to tackle possible heterogeneity in gene sets through the proposal of various gene set statistics, such as bi-directional regulation (Saxena et al., 2006; Wu et al., 2010) , yet a decision must be made in terms of the type of heterogeneity the gene set is displaying a priori. Therefore, there still lacks a systematic and effective means to determine heterogeneous expression of sub-patterns in time course datasets. Just very recently, Hejblum et al. (2015) called upon a close examination of the heterogeneity in gene sets where they used gap statistic (Tibshirani et al., 2001) to demonstrate that sub-clusters of genes in a gene set can exhibit distinct changes across time, yet these patterns are barely detectable by conventional methods. However, their approach is limited in the following ways: firstly, the gap statistic is a generic means to determine the optimal number of clusters, yet it does not take into account the dependency of gene expression between adjacent time points. Secondly, Hejblum et al., are mainly focused to investigate the heterogeneity in the expression dynamics under one condition, while in many cases, researchers are often interested in the 'dynamics of expression change' between biological groups (e.g. change of differential gene expression between healthy and unhealthy subjects during treatment). Finally, testing of heterogeneity is jointly performed with testing for the overall transcriptional changes of the gene set with no way to determine if a rejected test is specifically due to gene set heterogeneity. The gap statistic is only used as a post hoc visualization tool.
Hereby we develop a novel statistical software: Pareto Heterogeneity Analysis of Time-resolved Omics data on Modules (Phantom), to investigate the heterogeneity in gene sets and biological modules from time-course data. Based on Pareto front analysis, Phantom is the first statistical tool that is specifically designed to effectively detect heterogeneous gene sets for time-course studies under one or more biological conditions. A user-friendly web-based application of Phantom is implemented. t TÞ vs. the baseline expression ðt ¼ 0Þ; in a two-condition setting, x gt is the difference between conditions at time t ð0 t TÞ. To study the potential heterogeneity in gene set G, we first separate genes in G into K clusters c k ð1 k KÞ using hierarchical clustering (Fig. 1a) . We define two heterogeneity parameters for sub-cluster c k : a distance parameter d k (Euclidian distance between the mean of c k and its complementary set in G), and an effective size parameter p k (percentage of genes in c k ) (Fig. 1b) . We randomly down-sample N gene sets G null n ð1 n NÞ with exactly the same size of G from the global gene population to construct the reference null distribution ðd null n ; p null n Þ. A strong heterogeneous sub-cluster should have either larger distance d or size p, or both, compared to a random collection of genes. However, comparing ðd k ; p k Þ with the null distribution ðd null n ; p null n Þ is no trivial task, which involves the comparison of two objective functions whose joint distribution is intractable. Therefore, we introduce Pareto front analysis (Hero and Fleury, 2004) , a powerful tool used in multi-objective optimization, to resolve the issue of simultaneous comparison on multiple objective functions. Based on the principle of Pareto Dominance, high dimensional data points can be prioritized as a series of data sets known as the first Pareto front, the second Pareto front, and so forth. Each of the previous Pareto set dominates all the latter ones, which allows us to rank all highdimensional data points in the total space. In the case of a maximization problem, data on the first Pareto front are considered as 'larger than' data on the second Pareto front. Hence we can prioritize the 2D null distribution ðd null n ; p null n Þ (Fig. 1c) as a series of ordered Pareto sets. Data points on each Pareto set are associated with the same statistical significance by calculating the number of total data points that dominate them. Finally, the P-value of data point ðd k ; p k Þ is assigned based on the highest ranked Pareto set that it dominates. Phantom is implemented in R and has been optimized using C þþ (Supplementary Results S3). Details regarding implementation of Phantom can be found at Supplementary Methods.
Results
Dependency among time points can lead to 'over-clustering' when studying gene set heterogeneity using generic clustering evaluation methods, such as gap statistic. Phantom models the temporal dependency in the data by utilizing the global gene population to build a reference distribution, which offers accurate control of false positive rate (Supplementary Results S1 and S2).
We applied Phantom to an influenza dataset (Huang et al., 2011) to test gene set heterogeneity on the temporal change of differential expression between asymptomatic and symptomatic subjects after influenza inoculation (Supplementary Results S4 and S5). We systematically evaluated 13 different gene set collections from multiple sources including ten from Broad Molecular Signature Database (MSigDB v5.1) (Subramanian et al., 2005) , Baylor modules and Emory blood transcription modules (BTM) (Chaussabel and Baldwin, 2014; Li et al., 2014) , plus an in silico gene set simulated through random sampling. We define a gene set as heterogeneous if its P-value 0.05; on the other hand, gene sets with P-values ! 0.95 are regarded as more homogeneous than random gene sets.
Supplementary Figures S13 and S14 give the breakdown of the heterogeneity types for each gene set collections. Notably, Baylor modules and Emory BTMs contain the largest proportion of homogeneous gene sets (Baylor module: 105 out of 260 modules, 40%; Emory BTM: 151 out of 246 modules, 43%) and very few heterogeneous gene sets (Baylor module: 6 out of 260 modules, 2.3%; Emory BTM: 24 out of 346 modules, 6.9%). Baylor modules and Emory BTMs are computational elicited modules derived from coexpression analysis of multiple blood genomics datasets. The fact that a big chunk of the Baylor and Emory modules are reported to have more homogeneous transcriptional changes in the influenza dataset indicates that the co-regulation patterns summarized by these modules can be well-generalized to independent new datasets. We further investigate all the homogeneous gene sets from the 12 gene set collections by separating them into homogeneously up-and down-regulated in symptomatic subjects (Supplementary Figures  S17 and S18 ). Among the up-regulated gene sets, several of them display strong activation of gene expression starting from 36-to 45-h post-inoculation (hpi), which is highly correlated with the clinical symptom score of the symptomatic subjects (Huang et al., 2011) . These gene sets are featured by interferon activity (Baylor: M1.2, M3.4, M5.12; Emory M127;GO_BP: interferon gamma) and inflammatory response (Emory: M33;GO_BP: interleukins 1/8), which characterize multiple viral sensing mechanisms in the symptomatic phenotype. For the down-regulated homogeneous gene sets, new evidences on T cell activation and differentiation (Baylor: M4.1; Emory: M7.4, M14; Biocarta: TCR pathway) have been compiled which further support the hypotheses by Huang et al. that early involvement of Th1-type adaptive immunity may contribute to viral control in asymptomatic subjects without excessive inflammation (Huang et al., 2011) .
On the contrary, several other gene set collections including hallmark gene set, Reactome pathways, and transcription factor binding cites, exhibit more heterogeneous gene expression compared to random gene sets (Hallmark: 9 out of 50 gene sets, 18%; Reactome: 73 out of 674 gene sets, 11%; TF binding: 97 out of 615 gene sets, 16%). Upon close examination, we have discovered that for some of the identified heterogeneous Broad gene sets, a sub-cluster of genes go through a strong up-regulation of gene expression at around 45 hpi, which is sustained till the end of the study at 108 hpi. This change of expression pattern highly resembles the change of previously described homogeneous interferon gene sets. To validate whether these heterogeneous sub-clusters are indeed associated with interferon activity, we upload them to the interferome (v2.01) (Rusinova, et al., 2013) , which is a comprehensive database collecting interferon regulated genes from high-throughput data sets. The search result (species: Homo sapiens; system: haemopoietic/immune) is listed in Supplementary Table S6 . From Supplementary Table S6 , we see that almost all of the genes in the heterogeneous sub-clusters are regulated by one or more types of interferon (IFN I, II and III), which provides strong evidence that these sub-clusters may be direct regulatory targets of interferon or are functionally involved in interferon related pathways. Noteworthily, we cannot discover such IFN-related sub-components using conventional gene set methods since these gene sets typically have insignificant average expression change across time.
Once a heterogeneous gene set has been identified, Phantom will split the gene set into new sub-gene sets. These new sub-gene sets typically display more homogeneous expression dynamics, which can be feed into conventional time course gene set analysis tools. As an example, we have applied Q-Gen (Turner et al., 2015) , a selfcontained generalized quantitative gene set analysis approach, to 44 heterogeneous gene sets (before and after splitting) identified from 674 Reactome pathways to evaluate the statistical significance of average fold-change within gene sets being different from zero. Figure 2a -c and Supplementary Figure S19 give the heatmap of Àlog ðP À valueÞ Â signðlog ðFCÞÞ tested by Q-Gen on the 44 heterogeneous Reactome gene sets both before and after splitting. FC denotes the fold change between symptomatic and asymptomatic subjects. The majority of the un-split raw gene sets show unchanged relative gene expression between the two groups of subjects throughout most of the time points, except for a peaked change at 60 hpi. On the contrary, after these heterogeneous gene sets are split by Phantom, we observe strong up/down-regulation of gene expression between 45 and 108 hpi, which are highly correlated with the previously described dynamic change of interferon activity. Hence, by splitting heterogeneous gene sets into sub-clusters, Phantom effectively reshaped our conclusion regarding the global temporal dynamics: shifting from a single burst of expression change at 60 hpi to an interferon associated transcription regulation between 45 and 108 hpi (Fig. 2d) .
Conclusion
Phantom is the first statistical method to evaluate the heterogeneity in gene sets from time-course data. Phantom significantly improves the detection of heterogeneous temporal dynamics within a gene set that are previously undetectable at the overall level by conventional gene set methods. It is worth to note that in complicated gene sets and pathways, up and down-regulated sub-dynamics identified by Phantom may show strong inverse correlation, which we refer to as 'coordinative' heterogeneity as opposed to 'distinctive' heterogeneity. While distinctive heterogeneity typically emerges when the query gene set is not well generalized to new studies on different tissue types or conditions, coordinative heterogeneity, on the other hand, implies that the detected up and down components are orchestrated by common biological process through synchronized transcription activation or suppression. Further details regarding different types of heterogeneity are provided in the Supplementary Results S6.
Funding
This work was supported by the National Institutes of Health, under grants [U19AI089987, U19AI082715, P50AR070594-01].
Conflict of Interest: none declared. 
